Exosome Modules and Hydrogel Boost Diabetic Foot Healing
Summary: A new injectable hydrogel loaded with exosome modules dramatically accelerates diabetic foot ulcer (DFU) closure in preclinical models. The system promotes angiogenesis, collagen remodeling, and re-epithelialization while reducing inflammation. Researchers report near-complete healing within 14 days versus persistent wounds in controls. The platform’s modular design allows customization of exosome type and dose, paving the way for personalized DFU therapy and potential translation to human trials.
Key Highlights:
- Technology: Injectable hydrogel + engineered exosome modules.
- Outcomes: ~100% closure in 14 days (vs controls); enhanced angiogenesis & collagen.
- Advantages: Modular, tunable, anti-inflammatory, pro-regenerative.
- Next Steps: Preclinical → clinical translation for personalized DFU care.
- Authors: Not specified (ScienMag summary of peer-reviewed study).
Keywords: exosome, hydrogel, diabetic foot ulcer, angiogenesis, personalized medicine, regenerative